Vir Biotechnology Stock Technical Analysis
| VIR Stock | USD 7.12 0.17 2.45% |
As of the 25th of November, Vir Biotechnology has the Risk Adjusted Performance of (0.02), variance of 18.34, and Coefficient Of Variation of (2,858). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vir Biotechnology, as well as the relationship between them. Please validate Vir Biotechnology market risk adjusted performance and treynor ratio to decide if Vir Biotechnology is priced more or less accurately, providing market reflects its prevalent price of 7.12 per share. Given that Vir Biotechnology has information ratio of (0.07), we advise you to double-check Vir Biotechnology's current market performance to make sure the company can sustain itself at a future point.
Vir Biotechnology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vir, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VirVir |
Vir Biotechnology Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 32.75 | Buy | 9 | Odds |
Most Vir analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vir stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vir Biotechnology, talking to its executives and customers, or listening to Vir conference calls.
Vir Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Vir Biotechnology Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vir Biotechnology volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Vir Biotechnology Trend Analysis
Use this graph to draw trend lines for Vir Biotechnology. You can use it to identify possible trend reversals for Vir Biotechnology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Vir Biotechnology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Vir Biotechnology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Vir Biotechnology applied against its price change over selected period. The best fit line has a slop of 0.01 , which may imply that Vir Biotechnology will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 3.0, which is the sum of squared deviations for the predicted Vir Biotechnology price change compared to its average price change.About Vir Biotechnology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vir Biotechnology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vir Biotechnology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vir Biotechnology price pattern first instead of the macroeconomic environment surrounding Vir Biotechnology. By analyzing Vir Biotechnology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vir Biotechnology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vir Biotechnology specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Payables Turnover | 0.44 | 0.41 | Days Of Inventory On Hand | 42.86 | 38.1 |
Vir Biotechnology November 25, 2024 Technical Indicators
Most technical analysis of Vir help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vir from various momentum indicators to cycle indicators. When you analyze Vir charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 2.67 | |||
| Coefficient Of Variation | (2,858) | |||
| Standard Deviation | 4.28 | |||
| Variance | 18.34 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.83) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 35.87 | |||
| Value At Risk | (5.81) | |||
| Potential Upside | 5.41 | |||
| Skewness | 2.28 | |||
| Kurtosis | 14.5 |
Additional Tools for Vir Stock Analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.